7.42
-0.2(-2.62%)
Currency In USD
| Previous Close | 7.62 |
| Open | 7.58 |
| Day High | 7.58 |
| Day Low | 7.18 |
| 52-Week High | 61.9 |
| 52-Week Low | 4.64 |
| Volume | 91,110 |
| Average Volume | 172,914 |
| Market Cap | 90.8M |
| PE | -1.75 |
| EPS | -4.24 |
| Moving Average 50 Days | 6.58 |
| Moving Average 200 Days | 17.57 |
| Change | -0.2 |
If you invested $1000 in Corbus Pharmaceuticals Holdings, Inc. (CRBP) 10 years ago, it would be worth $76.93 as of June 01, 2025 at a share price of $7.42. Whereas If you bought $1000 worth of Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares 5 years ago, it would be worth $33.83 as of June 01, 2025 at a share price of $7.42.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 22, 2025 12:00 PM GMT
NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and parti
Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
GlobeNewswire Inc.
May 19, 2025 12:00 PM GMT
NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors,
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire Inc.
May 08, 2025 12:00 PM GMT
Norwood, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and o